WORLD LEADING PARASITOLOGY AND MYCOLOGY TEST KITS
RAPID LATERAL FLOW TEST FOR BRUCELLA CANIS NOW AVAILABLE
Q-TOX FACTOR-X ACTIVATOR RVV-X NOW AVAILABLE
COST EFFECTIVE VETERINARY DIAGNOSTICS NOW AVAILABLE
Featured Products
Our Product Ranges
Recieve our latest news
Sign up to our newsletterOur Company
With over 30 years of trading experience, Quadratech Diagnostics Limited has always been and remains committed to providing the highest quality state-of-the-art medical diagnostic and research products. Since the company was founded in 1990, we have expanded to encompass the following main areas: Haemostasis, Antigens, Antibodies and Toxins, Rapid and POC Tests, Parasitology and Veterinary.
Quadratech Diagnostics Limited is a corporate member of the Institute of Biomedical Scientists (IBMS) and the British Society for Haemostasis and Thrombosis (BSHT). We are a recognised supplier to the UK National Health Service (NHS), the Irish Health Service Executive (HSE), private laboratories, the UK pharmaceutical industry, and university research groups. Quadratech Diagnostics Limited became incorporated as a limited company in 1998 and is ISO 9001:2015 certified.
Our Product Brands
Latest News
Parasitology & Mycology March 2025 Journal Club
Keep informed about evolving science and clinical practice with our March 2025 compilation of the latest studies, guidelines, and perspectives in parasitology & mycology. ANISAKIDOSIS Bellini I, Scribano D, Ambrosi C, et al. Anisakis extracellular vesicles elicit immunomodulatory and potentially tumorigenic outcomes on human intestinal organoids. Parasites Vectors. 2024;17, 393. doi:10.1186/s13071-024-06471-7 ASPERGILLOSIS Aufiero MA, Hung L-Y, Herbert DR, […]
Chromogenic Substrates in Haemostasis
Chromogenic substrates are small synthetic peptides which mimic the natural substrate of the enzyme and have a detector chromophore, typically para-nitroaniline (pNA), attached to the cleavage site. Enzymatic cleavage releases pNA and results in a colour change, which can be followed spectrophotometrically and is proportional to the activity of the enzyme. The concept of chromogenic […]
Haemostasis January & February 2025 News
Our round-up of the latest developments from across the haemostasis industry for January & February 2025. REGULATORY Star Therapeutics’ VGA039 (Protein S mAb) granted FDA Fast Track designation for the treatment of Von Willebrand disease (VWD) (7 Jan) CLINICAL PharmaEssentia announced positive topline Ph3 data from SURPASS-ET study evaluating Ropeginterferon Alfa-2b-njft (P1101) for Essential Thrombocythemia […]
